IsoEnergy arranges $50-million bought deal financing

Executive Summary

• IsoEnergy Ltd. has entered into an agreement for a $50 million bought deal financing of 3,333,400 common shares at $15 per share, with Stifel Nicolaus Canada Inc. acting as sole bookrunner.
• The company is concurrently completing a non-brokered private placement of up to 1,666,666 shares with NexGen Energy Ltd. for up to $25 million to maintain NexGen's pro rata ownership interest at approximately 30%.
• Gross proceeds from both the bought deal and the concurrent private placement are intended to finance the continued development and exploration of IsoEnergy's mineral properties and for general corporate purposes.

Key Details

• Bought Deal Structure:
  • Issuer: IsoEnergy Ltd.
  • Underwriter: Stifel Nicolaus Canada Inc. (sole bookrunner) and a syndicate of underwriters.
  • Instrument: 3,333,400 common shares.
  • Price: $15.00 per common share.
  • Gross Proceeds: $50,001,000.
  • Overallotment Option: The underwriters have an option to purchase up to an additional 500,010 common shares at $15 per share, exercisable within 30 days of closing.
  • Potential Additional Proceeds: If the overallotment option is exercised in full, an additional $7,500,150 will be raised, bringing aggregate gross proceeds to $57,501,150.
• Concurrent Private Placement:
  • Investor: NexGen Energy Ltd.
  • Shares: Up to 1,666,666 common shares.
  • Price: $15.00 per share.
  • Aggregate Gross Proceeds: Up to approximately $25,000,000.
  • Purpose: To enable NexGen to maintain its pro rata ownership interest in IsoEnergy at approximately 30% after the offering.
  • Restrictions: Shares issued in the private placement are subject to a restricted hold period of four months and one day following the closing of the private placement.
  • Fees: No commission or other fee is payable to the underwriters for the private placement shares.
• Use of Proceeds:
  • Financing the continued development and further exploration of the company's mineral properties.
  • General corporate purposes.
• Regulatory and Listing Details:
  • Jurisdictions: Offered via prospectus supplement in all Canadian provinces and territories except Quebec, and in the United States on a private placement basis.
  • Filing: Prospectus supplement and base shelf prospectus accessible via SEDAR+ within two business days.
  • Closing Date: Scheduled on or about January 27, 2026.
  • Conditions: Subject to receipt of all necessary approvals to list the common shares on required exchanges, which must be conditionally approved prior to closing.

Notable Quotes

• No direct quotes from the CEO or President were included in the provided text.